1,417 results on '"Devroey, Paul"'
Search Results
2. Do the risks of preimplantation genetic testing for aneuploidy outbalance the benefits?
3. No need for luteal phase support in IVF cycles after mild stimulation: proof-of-concept study
4. Wiegen die Vorteile des genetischen Präimplantationstests für Aneuploidie die Risiken auf?
5. Oocytes collected from small follicles after a dual trigger with gonadotropin-releasing hormone agonist (Gn-RHa) and human chorionic gonadotropin (hCG) for final oocyte maturation, in poor responder patient do not impact negatively ICSI cycles outcomes
6. Low tolerance for complications
7. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study
8. Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study
9. Genetic Problems and Congenital Malformations in 1987 ICSI Children
10. Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study
11. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors
12. Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial
13. Clinical validation of a closed vitrification system in an oocyte-donation programme
14. Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial
15. Long-acting recombinant FSH (FSH-CTP, Corifollitropin alfa)
16. Fine-tuning the role of GnRH antagonists in ART programs
17. No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa
18. Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response
19. Adenomyosis
20. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination?
21. Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen–thawed embryo transfer cycles
22. Primary ovarian insufficiency
23. Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer
24. In Vitro Fertilization and Preimplantation Diagnosis
25. Sex Steroid Hormones and Reproductive Disorders: Impact on Women’s Health
26. Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation
27. Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles
28. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis
29. Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women
30. The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract
31. Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone
32. PGD for aneuploidy screening: an expensive hoax?
33. Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes
34. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis
35. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol
36. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos
37. Multiple birth resulting from ovarian stimulation for subfertility treatment
38. Human trophectoderm cells are not yet committed
39. Contributors
40. Ovulation Induction and Assisted Reproduction
41. Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers
42. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles
43. Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles
44. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study
45. Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome
46. AMH for predicting poor ovarian responders in GnRH antagonist cycles
47. Are ICSI adolescents at risk for increased adiposity?
48. The luteal phase
49. An OHSS-Free Clinic by segmentation of IVF treatment
50. Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.